FindTrial
Sign In

use of lasunadi ghrita by oral route and lasunadi taila by uterine route in female infertility.

Role of lasunadi ghrita oral and lasunadi taila uttarbasti in bandhyatva ( female infertility)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024309
Enrollment
30
Registered
2020-03-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: N979- Female infertility, unspecified

Interventions

Intervention1: Lasundai ghrita oral Lasunadi taila uttarbasti: Lasundai ghrita 6gm BD with meal by oral route for 3 months and Lasundai taila Uttarbasti by uterine route 3-5ml after cessation of menst

Sponsors

Preeti Agarwal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Married female patients of reproductive age (age-group 20-40 years) with the husbandâ??s normal Semenogram. 2. Female having complain of failure to conceive with one or more years after regular unprotected coitus. 3. Primary & secondary both types of infertility will be included for the study.

Exclusion criteria

Exclusion criteria: 1. Patient suffering form acute and chronic medical and systemic disease like jaundice, hypertension, diabetes mellitus,T.B.,Heart disease. 2.patient having congenital anomaly,chromosomal defect. 3.patient having immunological disorder. 4.secondary infertility with bad obstetrics history. 5.excluding male infertility.

Design outcomes

Primary

MeasureTime frame
ConceptionTimepoint: 3 month—

Secondary

MeasureTime frame
ConceptionTimepoint: 3 months—

Countries

India

Contacts

Public ContactPreeti Agarwal

Uttarakhand Ayurved University Rishikul Campus Haridwar

kalpnarishikul@gmail.com9410902002

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026